SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
SEC Accession No. 0001193125-20-259817
Filing Date
2020-09-30
Accepted
2020-09-30 17:00:59
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC 14D9/A d11782dsc14d9a.htm SC 14D9/A 17597
2 EX-99.(A)(5)(G) d11782dex99a5g.htm EX-99.(A)(5)(G) 121912
3 GRAPHIC g11782dsp026.jpg GRAPHIC 276326
  Complete submission text file 0001193125-20-259817.txt   521866
Mailing Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210 617-207-0202
AKCEA THERAPEUTICS, INC. (Filed by) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210 617-207-0202
AKCEA THERAPEUTICS, INC. (Subject) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A | Act: 34 | File No.: 005-90051 | Film No.: 201212964
SIC: 2834 Pharmaceutical Preparations